Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LYEL · NASDAQ · Pharmaceutical Preparations
$13.80+0.22 (+1.62%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Lyell Immunopharma (LYEL) · oqro.io/stocks/LYEL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
CEO sold ~$8.7K of LYEL shares in the open marketSourceInsider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
Officer sold ~$6.6K of LYEL shares in the open marketSourceInsider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
Officer sold ~$1.4K of LYEL shares in the open marketSourceInsider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
Officer sold ~$2.1K of LYEL shares in the open marketSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
10% owner purchased ~$25M of LYEL shares in the open marketSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
10% owner purchased ~$25M of LYEL shares in the open marketSourceInsider trade · Traded Oct 12, 2026 · Filed Oct 13, 2026
Officer sold ~$3.6K of LYEL shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 22, 2025
CEO sold ~$77K of LYEL shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 22, 2025
CFO sold ~$15K of LYEL shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 22, 2025
Officer sold ~$15K of LYEL shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 22, 2025
Officer sold ~$11K of LYEL shares in the open marketSourceInsider trade · Traded Mar 31, 2025 · Filed Apr 2, 2025
Director purchased ~$20K of LYEL shares in the open marketSourceInsider trade · Traded Mar 21, 2025 · Filed Mar 25, 2025
Director purchased ~$115K of LYEL shares in the open marketSourceInsider trade · Traded Mar 14, 2025 · Filed Mar 19, 2025
Director purchased ~$95K of LYEL shares in the open marketSourceInsider trade · Traded Mar 14, 2025 · Filed Mar 18, 2025
CEO purchased ~$106K of LYEL shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 18, 2025
CFO purchased ~$112K of LYEL shares in the open marketSourceInsider trade · Traded Aug 12, 2025 · Filed Aug 14, 2025
CEO sold ~$4.2K of LYEL shares in the open marketSourceInsider trade · Traded Aug 11, 2025 · Filed Aug 14, 2025
CEO sold ~$4.1K of LYEL shares in the open marketSourceInsider trade · Traded Aug 12, 2025 · Filed Aug 14, 2025
CFO sold ~$1.4K of LYEL shares in the open marketSourceInsider trade · Traded Aug 11, 2025 · Filed Aug 14, 2025
CFO sold ~$1.4K of LYEL shares in the open marketSourceInsider trade · Traded Aug 11, 2025 · Filed Aug 14, 2025
Officer sold ~$958 of LYEL shares in the open marketSourceInsider trade · Traded Aug 12, 2025 · Filed Aug 14, 2025
Officer sold ~$972 of LYEL shares in the open marketSourceInsider trade · Traded Aug 12, 2025 · Filed Aug 14, 2025
Officer sold ~$1.4K of LYEL shares in the open marketSourceInsider trade · Traded Aug 11, 2025 · Filed Aug 14, 2025
Officer sold ~$1.4K of LYEL shares in the open marketSource